Exogene

Developer of AI-powered T-cell-receptor-based immunotherapies for cancer treatment

placeOxford, England, United Kingdom calendar_todayFounded 2019 groups4 employees language exogene.co.uk

Registered entities

Social engagement

Social engagement: 2.8K social following, 6 posts in the last 12 months — above the industry median.

Investor mix

8 investors on record; lead investors include Selvedge Venture.

Investor typeCountShare
Venture capital450%
Accelerator & incubator113%
Other / undisclosed338%

Recent activity

1 Oct 2025
Milestone
users
30 Sep 2025
Partnership
UK Research and Innovation
Coming soon